SCHEMBL3452409

SCHEMBL3452409

COc1cc2c(cc1OC)C(CN1CCCC1)NCC2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.58
ACHE P22303 2/20 0.58
KMT2A Q03164 2/20 0.56
MAOA P21397 2/20 0.55
TSHR P16473 1/20 0.55
KDM4C Q9H3R0 1/20 0.53
SLC2A1 P11166 1/20 0.52
GRIN2D O15399 4/20 0.51
GRIN3B O60391 4/20 0.51
GRIN1 Q05586 4/20 0.51
GRIN2A Q12879 4/20 0.51
GRIN2B Q13224 4/20 0.51
GRIN2C Q14957 4/20 0.51
GRIN3A Q8TCU5 4/20 0.51
RAB9A P51151 1/20 0.51
TP53 P04637 1/20 0.51
CYP3A4 P08684 1/20 0.51
NFKB1 P19838 1/20 0.51
MAPK1 P28482 1/20 0.51
THPO P40225 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9529368 0.82 BCHE (0.48) BCHEACHEKMT2AGRIN2DGRIN3B
SCHEMBL3453137 0.82 HTR2A (0.49) BCHEACHEKMT2AKDM4CGRIN2D
SCHEMBL329846 0.81 BCHE (0.49) BCHEACHEKMT2AGRIN2DGRIN3B
SCHEMBL1818790 0.80 KMT2A (0.64) BCHEKMT2AMAOATSHRKDM4C
SCHEMBL13193462 0.80 KMT2A (0.64) BCHEKMT2AMAOATSHRKDM4C
SCHEMBL1817701 0.79 BCHE (0.65) BCHEKMT2AMAOATSHRKDM4C
SCHEMBL7851268 0.79 KMT2A (0.71) BCHEKMT2AMAOATSHRKDM4C
SCHEMBL3667523 0.79 BCHE (0.65) BCHEKMT2AMAOATSHRKDM4C
SCHEMBL11819007 0.79 KMT2A (0.63) BCHEKMT2AMAOATSHRKDM4C
Bisobrin SCHEMBL11618791 0.79 KMT2A (0.63) BCHEKMT2AMAOATSHRKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820692-B2 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof CHINA PHARMACEUTICAL UNIVERSITY (CN) 2010-10-26 US disclosed
US-20090275607-A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof CHINA PHARMACEUTICAL UNIVERSITY (CN) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275607-A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof OPRK1, OPRD1, OPRL1 BCHE 1556/4885ACHE 312/4885KMT2A 1319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.